About IMAT

The Innovative Molecular Analysis Technologies (IMAT) program was established to support the development, technical maturation, and dissemination of novel and potentially transformative next-generation technologies through an approach of balanced but targeted innovation. In support of its mission, the IMAT program utilizes a variety of investigator-initiated research project grant mechanisms while retaining a strong commitment to diversity and to the training of scientists and clinicians in cross-cutting, research-enabling disciplines.



Other Funding Opportunities

The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) aims to develop a framework for functional mapping the human body...

New RFA to support Academic-Industrial Partnerships for technologies to capture and quantify...

NCI’s Office of Cancer Nanotechnology Research has published a new funding opportunity announcement for the Innovative Research in Cancer Nanotechnology (IRCN) initiative,...

The NCI is soliciting R01 applications for improved biomimetic tissue engineering platforms as part of a new cancer tissue engineering collaborative. Multiple due dates through...

Pages